Publication | Closed Access

Pharmacokinetics, pharmacodynamics and clinical effects of the oral direct thrombin inhibitor ximelagatran in acute treatment of patients with pulmonary embolism and deep vein thrombosis

Acute TreatmentPulmonary EmbolismThrombosisVenous ThrombosisCardiovascular DiseaseMedicineDeep Vein ThrombosisHematologyPharmacotherapyPublic HealthPlatelet AntagonistPharmacologyAnticoagulant